Sb203580
SB203580 is a selective inhibitor of p38 mitogen-activated protein kinase (MAPK). It is a small molecule that binds to and inhibits the enzymatic activity of the p38 MAPK isoforms.
Lab products found in correlation
67 protocols using sb203580
Akirin1 Regulates Myoblast Proliferation and Differentiation
Bile Acids and Kinase Inhibitor Preparation
Signaling Pathways in H2O2-Induced Granulosa Cell Responses
Reagents and Antibodies for Cell Assays
LPS-Induced Inflammatory Response in RAW 264.7 Cells
In the signaling pathway inhibition experiments, the cells were first treated with the signaling pathway inhibitor BAY 11-7082 (Beyotime, Shanghai, China; 10 μM), U0126 (Beyotime, Shanghai, China; 10 μM), SB203580 (Beyotime, Shanghai, China; 20 μM) or SP600125 (Beyotime, Shanghai, China; 20 μM) for 1 h, and were then stimulated with 1 μg/mL LPS for 6 h. Cells not stimulated with LPS or treated with signaling pathway inhibitors were used as a blank control.
Bovine IL-1α Signaling Pathway Analysis
Solid-Phase Synthesis of EM-1 and EM-2 Peptides
Naloxone, β-FNA, nor-binaltorphimine (nor-BNI), and naltrindole (NTI) were obtained from Sigma-Aldrich. The selective p38 MAPK inhibitor SB203580 was purchased from Beyotime Institute of Biotechnology and dissolved in 1% DMSO in saline. All other drugs were dissolved in sterilized saline and stored at − 20 °C.
Evaluating RPMTG's Effects on CRC Cell Lines
Cobrotoxin-Induced Cytotoxicity Mechanism
Hypoxia-Induced HaCaT Cell Response
Hypoxic conditions of 1% O2, 5% CO2, and 94% N2 were produced utilizing an oxygen control incubator (model: 3131; Thermo Scientific). The p38/MAPK inhibitor SB203580 (Beyotime) (5 μmol/l) was added to these cultures and incubated at 37°C for 30 minutes before hypoxia treatment. In addition the ADAM17 inhibitor, TAPI-2 (40 μM) was added to the cultures and incubated at 37°C for 12 hours before hypoxia treatment.
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!